Your browser does not support JavaScript capabilities, which maybe required to display this page properly.


PDF FormatRequires Adobe Acrobat Reader

Table 8.6c

Immunosuppression Use for Induction by Steroid Use at Discharge, 2004 to 2008

Recipients with Kidney-Pancreas Transplants

  No Steroids Used for Maintenance Steroids Used for Maintenance
N % N %
Functioning Graft with Immunosuppression Info at Discharge 1,298 100.0% 2,969 100.0%
Induction Drugs        
Atgam/NRATG/NRATS 19 1.5% 56 1.9%
OKT3 1 0.1% 17 0.6%
Thymoglobulin 810 62.4% 1,485 50.0%
Zenapax 8 0.6% 222 7.5%
Simulect 38 2.9% 302 10.2%
Campath 307 23.7% 271 9.1%
Rituximab 10 0.8% 6 0.2%
No Induction Drug Reported 163 12.6% 686 23.1%


Source: OPTN/SRTR Data as of May 4, 2009.

Includes patients with a functioning graft at discharge.

Steroids used for induction are not counted.

Individual induction drug percentages will not necessarily add up to 100 percent, as patients may be prescribed more than one induction drug.



PDF FormatRequires Adobe Acrobat Reader